Adverse Reactions and Therapeutic Approaches in the Treatment of COVID-19-Induced Viral Myocarditis

Authors

  • Chen Zijiu Yunnan Charming Handao Pharmaceutical Technology Co., Ltd. Kunming 650100, Yunnan Province, China;
  • Zhou Xin Wuxi People’s Hospital, Wuxi 214000, Jiangsu Province, China
  • Li Chunhong Ruili Jingcheng Hospital of Yunnan Province, Ruili 678600, Yunnan Province, China
  • Luo Yixiao Yunnan Charming Handao Pharmaceutical Technology Co., Ltd. Kunming 650100, Yunnan Province, China
  • Yang Jianbo Yunnan Charming Handao Pharmaceutical Technology Co., Ltd. Kunming 650100, Yunnan Province, China
  • Wang Zhongyi Xi’an Jiaotong Liverpool University, Suzhou 215123, Jiangsu Province, China

Keywords:

COVID-19, Myocarditis, Healthcare management

Abstract

In recent years, an increasing number of sudden deaths among middle-aged and young adults in sub-health conditions caused by COVID-19-related myocarditis have underscored the virus’s potential threat to this population. At present, there is no specific treatment for viral myocarditis, and commonly used antiviral drugs often cause adverse reactions. This paper explores a novel therapeutic strategy for viral myocarditis by adopting the integrative approach of Chinese and Western medicine that has proven effective in cancer treatment. Mechanistically, this approach appears feasible. Continuous innovation in clinical medicine is essential to benefit patients..

References

Chen, T., & Liu, Z. (2017). A herbal formula, SYKT, reverses doxorubicin-induced myelosuppression and cardiotoxicity by inhibiting ROS-mediated apoptosis. Molecular Medicine Reports, 15, 2057–2066.

Chimenti, C., Magnocavallo, M., Ballatore, F., et al. (2022). Prevalence and clinical implications of COVID-19 myocarditis. Cardiac Electrophysiology Clinics, 14(1), 53–62. https://doi.org/10.1016/j.ccep.2021.11.001

Chinese Society of Cardiology, & Working Group on Adult Fulminant Myocarditis. (2017). Chinese expert consensus on the diagnosis and treatment of adult fulminant myocarditis. Chinese Journal of Cardiovascular Diseases, 45(9), 742–752.

Gluckman, T. J., Bhave, N. M., Allen, L. A., et al. (2022). 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play. Journal of the American College of Cardiology, 79(17), 1717–1756.

Goodnow, C. (n.d.). Reflection of an Australian Immunologist: From COVID-19 Infection to Myocarditis. Australian Broadcasting Corporation (ABC).

Heart Failure Committee of the Chinese Medical Doctor Association. (2022). China expert recommendation on infection-related myocarditis associated with COVID-19. Chinese Journal of Heart Failure and Cardiomyopathy, 6(4), 280–287.

Huang, C., Wang, Y., Li, X., et al. (2020). Clinical features of patients infected with the 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223), 497–506.

Lala, A., Johnson, K. W., Russak, A. J., et al. (2020). Prevalence and impact of myocardial injury in patients hospitalized with COVID-19. Journal of the American College of Cardiology, 76(5), 533–546.

Lü, J., Wang, L., Li, W., Yin, W., et al. (2004). Concurrent use of SYKT during radiotherapy for locally advanced non-small-cell lung cancer. Chinese Journal of Oncology, 13(11), 64–67.

Ribavirin Tablets Drug Monograph. (n.d.). Yaozhi Pharmaceutical Database. https://db.yaozh.com/instruct/33238.html

Wang, D., Hu, B., Hu, C., et al. (2020). Clinical characteristics of 138 hospitalized patients with 2019-nCoV-infected pneumonia in Wuhan, China. JAMA, 323(11), 1061–1069.

Wang, L. (2020). Study on the Radiosensitization and Radioprotective Mechanism of SYKT [Doctoral dissertation]. Kunming Medical University. https://doi.org/10.2202/d.cnki.gkmyc.2018.11.

World Health Organization. (2021, December 16). Coronavirus disease (COVID-19): Post COVID-19 condition. https://www.who.int/news-room/questions-and-answers/item/coronavirusdisease-(covid-19)-post-covid-19-condition

Zhou, H., Sun, H., Zhao, P., et al. (2015). Effect of SYKT adjuvant radiochemotherapy on bone marrow suppression in patients with head and neck squamous cell carcinoma. Chinese Journal of Experimental Traditional Medical Formulae, 21(21), 173–176. https://doi.org/10.13422/j.cnki.syfjx.2015210173

Myocarditis concept image

Downloads

Published

29-04-2026

How to Cite

Zijiu, C., Xin, Z., Chunhong, L., Yixiao, L., Jianbo, Y., & Zhongyi, W. (2026). Adverse Reactions and Therapeutic Approaches in the Treatment of COVID-19-Induced Viral Myocarditis. International Healthcare Review (online). Retrieved from https://internationalhealthcarereview.com/index.php/home/article/view/185

Issue

Online First

Section

Expert Commentaries and Opinion

License

Copyright (c) 2026 The Publisher

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.